Last 12 months
Inside the activity.
1 purchase rows · 23 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 3 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 2 |
| Jun 2026 | 1 | 2 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 9 |
| Sep 2026 | 0 | 6 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 08, 2023 Filed Mar 9, 2023 23:26 UTC |
Ussery Robert MichaelPresident & COO
|
GrantOption to Purchase Common Stock · Derivative | 13,500 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006034 · rdgdoc.xml · derivative · entry 3 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,500 Underlying: Common Stock · 13,500 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:26 UTC |
Ussery Robert MichaelPresident & COO
|
GrantShares of Common Stock owned by myself & spouse | 1,332 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006034 · rdgdoc.xml · nonDerivative · entry 1 Ussery Robert Michael · CIK 0001313364 · President & COO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 149,754 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:25 UTC |
McIntosh Leroy E. Jr.SVP, Anc Srvcs & Srvc Strategy
|
GrantOption to Purchase Common STock · Derivative | 11,200 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006033 · rdgdoc.xml · derivative · entry 3 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:25 UTC |
McIntosh Leroy E. Jr.SVP, Anc Srvcs & Srvc Strategy
|
GrantShares of Common Stock | 619 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006033 · rdgdoc.xml · nonDerivative · entry 1 McIntosh Leroy E. Jr. · CIK 0001704110 · SVP, Anc Srvcs & Srvc Strategy 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,726.3938 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:20 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
GrantOption to Purchase Common Stock · Derivative | 7,500 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006029 · rdgdoc.xml · derivative · entry 3 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:20 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
GrantShares of Common Stock held in my name | 418 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006029 · rdgdoc.xml · nonDerivative · entry 1 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,017 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:19 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006027 · rdgdoc.xml · derivative · entry 3 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:19 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
GrantShares of Common Stock held in my name | 573 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006027 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,488.5455 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:17 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006025 · rdgdoc.xml · derivative · entry 3 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:17 UTC |
McCreary Josh ASenior VP & General Counsel
|
GrantShares of Common Stock | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006025 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,285 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:15 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantOption to Purchase Common Stock · Derivative | 15,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006023 · rdgdoc.xml · derivative · entry 3 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:15 UTC |
Flatt Stephen FowlerDirector · CEO
|
GrantCommon Stock | 1,502 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006023 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,996 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:04 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantOption to Purchase Common Stock · Derivative | 11,200 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006018 · rdgdoc.xml · derivative · entry 3 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,200 Underlying: Common Stock · 11,200 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:04 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
GrantShares of Common Stock | 697 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006018 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,417.8909 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:13 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
GrantOption to Purchase Common Stock · Derivative | 12,000 | $0.00 Strike: $53.94 | $0.00 |
DisclosureSEC source: 0001437749-23-006021 · rdgdoc.xml · derivative · entry 3 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,000 Underlying: Common Stock · 12,000 shares Expires 2028-03-08 F2 · shares: These stock options were granted pursuant to the Company's 2020 Omnibus Equity Incentive Plan on March 8, 2023. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F3 · derivative.exercise_date: This option will become vested and exercisable ratably over three (3) years so that one-third (1/3) will vest on March 8, 2024; one-third (1/3) will vest on March 8, 2025; and the final one-third (1/3) will vest on March 8, 2026. Read SEC document |
| March 08, 2023 Filed Mar 9, 2023 23:13 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
GrantShares of Common Stock held in my name | 728 | $0.00 | $0.00 |
DisclosureSEC source: 0001437749-23-006021 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,155 F1 · shares: Grant of restricted shares that are subject to a three-year vesting schedule with the first 33 1/3% vesting on 1/1/2024, the next 33 1/3% vesting on 1/1/2025, and the final 33 1/3% vesting on 1/1/2026. Read SEC document |
| February 23, 2023 Filed Feb 27, 2023 21:30 UTC |
ABERNATHY JAMES PAULDirector
|
PurchaseShares of Common Stock | 2,176 | $57.45 | $125,011.20 |
DisclosureSEC source: 0001437749-23-004762 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,390 Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:41 UTC |
SMITH JEFFREY RUSSELLSVP & Treasurer
|
Tax withholdingShares of Common Stock held in my name | 362 | $59.50 | $21,539.00 |
DisclosureSEC source: 0001437749-23-000358 · rdgdoc.xml · nonDerivative · entry 1 SMITH JEFFREY RUSSELL · CIK 0001694452 · SVP & Treasurer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,599 F1 · shares: On 1/1/2023, 33 1/3 (or 1,222 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 362 to pay tax obligations. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:28 UTC |
Flatt Stephen FowlerDirector · CEO
|
Tax withholdingCommon Stock | 824 | $59.50 | $49,028.00 |
DisclosureSEC source: 0001437749-23-000355 · rdgdoc.xml · nonDerivative · entry 1 Flatt Stephen Fowler · CIK 0001330766 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 55,494 F1 · shares: On 1/1/2023, 33 1/3 (or 2,780 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 824 to pay tax obligations. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:29 UTC |
FLATT BEN ANDERSON SRSenior VP & CIO
|
Tax withholdingShares of Common Stock | 362 | $59.50 | $21,539.00 |
DisclosureSEC source: 0001437749-23-000356 · rdgdoc.xml · nonDerivative · entry 1 FLATT BEN ANDERSON SR · CIK 0001699471 · Senior VP & CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,396.6456 F1 · shares: On 1/1/2023, 33 1/3 (or 1,221 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 362 to pay tax obligations. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:26 UTC |
Dodson Vicki LSr.VP Patient Srvcs
|
Tax withholdingShares of Common Stock held in my name | 194 | $59.50 | $11,543.00 |
DisclosureSEC source: 0001437749-23-000354 · rdgdoc.xml · nonDerivative · entry 1 Dodson Vicki L · CIK 0001779472 · Sr.VP Patient Srvcs 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,915.5455 F1 · shares: On 1/1/2023, 33 1/3 (or 655 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 194 to pay tax obligations. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:26 UTC |
KIDD BRIAN FSVP, Controller, PAO
|
Tax withholdingShares of Common Stock held in my name | 318 | $59.50 | $18,921.00 |
DisclosureSEC source: 0001437749-23-000353 · rdgdoc.xml · nonDerivative · entry 1 KIDD BRIAN F · CIK 0001693922 · SVP, Controller, PAO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,383 F1 · shares: On 1/1/2023, 33 1/3 (or 1,074 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 318 to pay tax obligations. Read SEC document |
| January 01, 2023 Filed Jan 4, 2023 22:20 UTC |
McCreary Josh ASenior VP & General Counsel
|
Tax withholdingShares of Common Stock | 297 | $59.50 | $17,671.50 |
DisclosureSEC source: 0001437749-23-000351 · rdgdoc.xml · nonDerivative · entry 1 McCreary Josh A · CIK 0001774116 · Senior VP & General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,557 F1 · shares: On 1/1/2023, 33 1/3 (or 1,002 shares) of restricted stock originally granted on 2/21/2020, 2/24/2021, and 2/25/2022 vested. The Company withheld 297 to pay tax obligations. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:29 UTC |
ADAMS W ANDREWDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-029385 · rdgdoc.xml · derivative · entry 6 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,480 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 15, 2022 Filed Dec 19, 2022 18:29 UTC |
ADAMS W ANDREWDirector
|
Exercise / conversionShares of Common Stock - my name or my spouse's name | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-22-029385 · rdgdoc.xml · nonDerivative · entry 1 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,990 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 19:07 UTC |
Trail Sandra Y.Director
|
Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,807 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-029129 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,690 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 13, 2022 Filed Dec 15, 2022 19:07 UTC |
Trail Sandra Y.Director
|
Exercise / conversionShares of Common Stock | 1,807 | $69.19 | $125,026.33 |
DisclosureSEC source: 0001437749-22-029129 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 13, 2022 Filed Jan 12, 2023 21:28 UTC Amendment |
Trail Sandra Y.Director
|
Exercise / conversionOption to Purchase Common Stock [2022 Grant] · Derivative | 1,807 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-23-000963 · rdgdoc.xml · derivative · entry 2 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,693 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · balance_after: Number of shares owned following transaction has been updated here to correct a mathematical error on the original form. Read SEC document |
| December 13, 2022 Filed Jan 12, 2023 21:28 UTC Amendment |
Trail Sandra Y.Director
|
Exercise / conversionShares of Common Stock | 1,807 | $69.19 | $125,026.33 |
DisclosureSEC source: 0001437749-23-000963 · rdgdoc.xml · nonDerivative · entry 1 Trail Sandra Y. · CIK 0001910870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,807 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| December 06, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 531 | $58.90 | $31,275.37 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 8 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,700 F1 · balance_after: Total amount of common shares owned following all transactions reported on this form. Read SEC document |
| December 05, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 1,929 | $61.15 | $117,953.72 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 7 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,231 Read SEC document |
| December 02, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 3,391 | $60.89 | $206,461.71 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 6 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,160 Read SEC document |
| December 02, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 4,261 | $61.23 | $260,901.46 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 5 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,551 Read SEC document |
| December 01, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 500 | $61.00 | $30,499.35 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 4 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 90,812 Read SEC document |
| December 01, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 388 | $60.37 | $23,423.99 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 3 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,312 Read SEC document |
| November 30, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 1,302 | $61.13 | $79,597.64 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 2 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,700 Read SEC document |
| November 30, 2022 Filed Dec 7, 2022 17:04 UTC |
BURGESS ERNEST G IIIDirector
|
SaleShares of Common Stock | 1,142 | $60.71 | $69,327.62 |
DisclosureSEC source: 0001437749-22-028675 · rdgdoc.xml · nonDerivative · entry 1 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 93,002 Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 10:49 UTC |
BURGESS ERNEST G IIIDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-019973 · rdgdoc.xml · derivative · entry 3 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 10, 2022 Filed Aug 11, 2022 10:49 UTC |
BURGESS ERNEST G IIIDirector
|
Exercise / conversionShares of Common Stock | 2,500 | $61.90 | $154,750.00 |
DisclosureSEC source: 0001437749-22-019973 · rdgdoc.xml · nonDerivative · entry 1 BURGESS ERNEST G III · CIK 0001012856 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 94,144 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 18, 2022 Filed May 19, 2022 19:26 UTC |
ADAMS ROBERT GDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 1,934 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-22-013037 · rdgdoc.xml · derivative · entry 4 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,566 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 18, 2022 Filed May 19, 2022 19:26 UTC |
ADAMS ROBERT GDirector
|
Exercise / conversionShares of Common Stock - Partnership | 1,934 | $64.64 | $125,013.76 |
DisclosureSEC source: 0001437749-22-013037 · rdgdoc.xml · nonDerivative · entry 1 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Indirect · General Partner Disclosed balance after: 430,341 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 11, 2022 Filed May 13, 2022 19:30 UTC |
ABERNATHY JAMES PAULDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,020 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-012335 · rdgdoc.xml · derivative · entry 2 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,460 Underlying: Common Stock · 5,480 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 11, 2022 Filed May 13, 2022 19:30 UTC |
ABERNATHY JAMES PAULDirector
|
Exercise / conversionShares of Common Stock | 2,020 | $61.90 | $125,038.00 |
DisclosureSEC source: 0001437749-22-012335 · rdgdoc.xml · nonDerivative · entry 1 ABERNATHY JAMES PAUL · CIK 0001261687 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 29,214 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 17:59 UTC |
ADAMS ROBERT GDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011300 · rdgdoc.xml · derivative · entry 7 ADAMS ROBERT G · CIK 0001012855 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC |
LAROCHE RICHARD F JRDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 11 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F5 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $64.64 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 9 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,000 Underlying: Common Stock · 7,500 shares Expires 2025-05-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionOption to Purchase Common Stock · Derivative | 2,500 | $0.00 Strike: $61.90 | $0.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · derivative · entry 7 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 2,500 shares Expires 2023-05-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionCommon Stock - Held in my name or my wife's name | 2,500 | $64.64 | $161,600.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · nonDerivative · entry 2 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,313 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 7, 2020. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F4 · balance_after: Total amount of shares beneficially owned following transactions reported for this "Title of Securities" on this form. Read SEC document |
| May 05, 2022 Filed May 6, 2022 19:56 UTC |
LAROCHE RICHARD F JRDirector
|
Exercise / conversionCommon Stock - Held in my name or my wife's name | 2,500 | $61.90 | $154,750.00 |
DisclosureSEC source: 0001437749-22-011337 · rdgdoc.xml · nonDerivative · entry 1 LAROCHE RICHARD F JR · CIK 0001012859 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 3, 2018. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). F2 · balance_after: Transactions for this "Title of Security" totaled on the line below. Read SEC document |
| May 05, 2022 Filed May 6, 2022 13:59 UTC |
ADAMS W ANDREWDirector
|
GrantOption to Purchase Common Stock [2022 Grant] · Derivative | 7,500 | $0.00 Strike: $69.19 | $0.00 |
DisclosureSEC source: 0001437749-22-011298 · rdgdoc.xml · derivative · entry 11 ADAMS W ANDREW · CIK 0001012853 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,500 Underlying: Common Stock · 7,500 shares Expires 2027-05-04 F1 · shares: These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 5, 2022. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d). Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.